Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
Condition(s):Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue SarcomaLast Updated:September 28, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue SarcomaLast Updated:September 28, 2023Recruiting
Condition(s):Breast CancerLast Updated:May 8, 2019Completed
Condition(s):Glioblastoma (GBM); DIPG; Brainstem Glioma, Pediatric; Diffuse Spinal Glioma; Bilateral Thalamic Glioma; Gliomatosis Cerebri; Anaplastic Astrocytoma; Midline Diffuse GliomaLast Updated:February 9, 2021Terminated
Condition(s):Dose Escalation: Solid Tumors; MTD: Soft Tissue SarcomasLast Updated:July 28, 2015Completed
Condition(s):Breast CancerLast Updated:November 21, 2023Terminated
Condition(s):Pancreas CancerLast Updated:October 4, 2023Recruiting
Condition(s):Cervical CancerLast Updated:January 27, 2021Unknown status
Condition(s):SarcomaLast Updated:August 19, 2019Unknown status
Condition(s):Liver CancerLast Updated:August 3, 2020Completed
Condition(s):Soft Tissue SarcomaLast Updated:December 9, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.